BKR Q2 Beat Reinforces IET Strength, But Overvaluation Concerns Persist

What happened

Baker Hughes reported Q2 earnings that beat analyst estimates, driven by continued margin expansion and a 49% surge in orders within its Industrial & Energy Technology (IET) segment. The record backlog now supports a stronger 2026 outlook, reinforcing the bull case of a structural growth engine offsetting cyclical weakness in Oilfield Services & Equipment. However, the DeepValue master report had already priced in such IET momentum, with the stock trading at ~21x earnings and ~17.5x EV/EBITDA, levels that leave little room for disappointment. The report flags elevated risk from the pending $13.6B Chart Industries acquisition, which will temporarily increase leverage, and from softening OFSE margins that could undermine consolidated growth. While the Q2 results are objectively positive, they do not alter the core thesis that current valuation already discounts a near-perfect execution scenario.

Implication

Investors should view the Q2 beat as a validation of the IET growth story but not a reason to chase the stock. The DeepValue report had already incorporated strong IET orders into its base case, which values BKR at $55, below the current $56.88 price. The Chart deal, while strategically sound, will push net leverage toward 2.25x and require flawless integration to achieve synergies—a risk not fully priced in if IET momentum were to slow. OFSE remains a drag, with revenue declines and margin pressure likely to persist amid constrained upstream spending. Therefore, the positive Q2 news does not change the cautious stance; trimming above $65 or waiting for a pullback near $48 offers a more attractive risk/reward. The thesis remains that potential return from new money is limited relative to downside risks.

Thesis delta

The Q2 beat confirms IET's operational momentum, but the DeepValue thesis already held that unit as the primary driver. It does not address the key risks: Chart integration leverage and OFSE weakness. Thus, the overall view remains unchanged: the stock is fairly to slightly overvalued, with asymmetric downside if any of those risks materialize.